Finder makes money from featured partners, but editorial opinions are our own. Advertiser Disclosure

How to buy Kala Pharmaceuticals stock

Learn how to easily invest in Kala Pharmaceuticals stock.

Kala Pharmaceuticals Inc is a drug manufacturers-specialty & generic business based in the US. Kala Pharmaceuticals shares (KALA) are listed on the NASDAQ and all prices are listed in US Dollars. Kala Pharmaceuticals employs 192 staff and has a trailing 12-month revenue of around $8.4 million.

How to buy shares in Kala Pharmaceuticals

  1. Compare share trading platforms. Use our comparison table to help you find a platform that fits you.
  2. Open your brokerage account. Complete an application with your details.
  3. Confirm your payment details. Fund your account.
  4. Research the stock. Find the stock by name or ticker symbol – KALA – and research it before deciding if it's a good investment for you.
  5. Purchase now or later. Buy your desired number of shares with a market order or use a limit order to delay your purchase until the stock reaches a desired price.
  6. Check in on your investment. Optimize your portfolio by tracking your stock.
Client disclaimer: US Brokerage services through eToro USA Securities Inc, member of FINRA, SIPC. Crypto assets through eToro USA LLC.

Kala Pharmaceuticals stock price (NASDAQ: KALA)

Use our graph to track the performance of KALA stocks over time.

Kala Pharmaceuticals shares at a glance

Information last updated 2022-09-22.
Latest market close$0.23
52-week range$0.25 - $3.00
50-day moving average $0.32
200-day moving average $0.75
Wall St. target price$2.31
PE ratio N/A
Dividend yield $0 (0%)
Earnings per share (TTM) $-2.14

Buy Kala Pharmaceuticals shares from these brokerages

Compare special offers, low fees and a wide range of types of investments among top trading platforms.
1 - 8 of 8
Name Product Asset types Stock trade fee Minimum deposit Signup bonus
SoFi Invest
Stocks, ETFs, Cryptocurrency
$10 - $100
when you open an account and place a first crypto trade of $50 - $5,000+
A free way to invest in most equities.
Stocks, ETFs, Cryptocurrency
8%-12% of your deposit
when you sign up and deposit at least $50. T&Cs apply.
Trade stocks in the app or online with $0 commissions. Not available in NY, NV, MN, TN, and HI.
Stocks, ETFs, Cryptocurrency
Receive a free stock slice worth between $3–$300
when you sign up for an account and deposit at least $20.
Commission-free trading in stocks and ETFs with a social networking twist.
Stocks, Options, ETFs, Cryptocurrency
$200 in US stocks
when you open and fund an account with min. $2,000 for 3+ mos.
Trade stocks, options, ETFs and futures on mobile or desktop with this advanced platform.
JPMorgan Self-Directed Investing
Stocks, Bonds, Options, Mutual funds, ETFs
$125 - $625
when you open and fund an account with $25,000 - $250,000+
Stocks, Options, ETFs, Cryptocurrency
Get a free stock
when you successfully sign up and link your bank account.
Make unlimited commission-free trades, plus earn 3% interest on uninvested cash in your account with Robinhood Gold.
Ally Invest Self-Directed Trading
Stocks, Bonds, Options, Mutual funds, ETFs
when you deposit or transfer $10,000–$24,900
500+ commission-free ETFs, some of the industry's lowest fees plus a cash bonus up to $3,000.
Stocks, Options, ETFs
Customize your trade platform or build your own Deep tools, charts and screens Analyzers to help you study before you trade

Compare up to 4 providers

*Signup bonus information updated weekly.

The value of any investment can go up or down depending on news, trends and market conditions. We are not investment advisers, so do your own due diligence to understand the risks before you invest.

Is it a good time to buy Kala Pharmaceuticals stock?

The technical analysis gauge below displays real-time ratings for the timeframes you select. This is not a recommendation, however. It represents a technical analysis based on the most popular technical indicators: Moving Averages, Oscillators and Pivots. Finder might not concur and takes no responsibility.

This chart is not advice or a guarantee of success. Rather, it gauges the real-time recommendations of three popular technical indicators: moving averages, oscillators and pivots. Finder is not responsible for how your stock performs.

Kala Pharmaceuticals price performance over time

Historical closes compared with the close of $0.2285 from 2022-09-26

1 week (2022-09-21) -21.07%
1 month (2022-08-26) -22.01%
3 months (2022-06-28) -32.79%
6 months (2022-03-24) -86.23%
1 year (2021-09-28) -92.28%
2 years (2020-09-28) -97.13%
3 years (2019-09-27) 4
5 years (2017-09-27) 23.53

Kala Pharmaceuticals financials

Revenue TTM $8.4 million
Gross profit TTM $7.1 million
Return on assets TTM -45.66%
Return on equity TTM -518.81%
Profit margin 0%
Book value $0.26
Market capitalisation $20.2 million

TTM: trailing 12 months

Kala Pharmaceuticals share dividends

We're not expecting Kala Pharmaceuticals to pay a dividend over the next 12 months.

Have Kala Pharmaceuticals's shares ever split?

Kala Pharmaceuticals's shares were split on a 1001:1000 basis on 25 August 2022. So if you had owned 1000 shares the day before before the split, the next day you'd have owned 1001 shares. This wouldn't directly have changed the overall worth of your Kala Pharmaceuticals shares – just the quantity. However, indirectly, the new 0.1% lower share price could have impacted the market appetite for Kala Pharmaceuticals shares which in turn could have impacted Kala Pharmaceuticals's share price.

Kala Pharmaceuticals share price volatility

Over the last 12 months, Kala Pharmaceuticals's shares have ranged in value from as little as $0.245 up to $3. A popular way to gauge a stock's volatility is its "beta".

KALA.US volatility(beta: 1.04)Avg. volatility(beta: 1.00)LowHigh

Beta is a measure of a share's volatility in relation to the market. The market (NASDAQ average) beta is 1, while Kala Pharmaceuticals's is 1.0419. This would suggest that Kala Pharmaceuticals's shares are a little bit more volatile than the average for this exchange and represent, relatively-speaking, a slightly higher risk (but potentially also market-beating returns).

Kala Pharmaceuticals overview

Kala Pharmaceuticals, Inc. , a biopharmaceutical company, focuses on the discovery, development, and commercialization of therapies using its proprietary mucus penetrating particles technology for the treatment of eye diseases. The company's product candidates include KPI-012, which is in clinical development stage for the treatment of persistent corneal epithelial defects; EYSUVIS for the short-term treatment of the signs and symptoms of dry eye disease; and INVELTYS, a topical twice-a-day ocular steroid for the treatment of post-operative inflammation and pain following ocular surgery. Its preclinical development products comprise KPI-287 that inhibits the vascular endothelial and platelet derived growth factors for the treatment of retinal diseases, including wet age-related macular degeneration, diabetic macular edema, and retinal vein occlusion; and selective glucocorticoid receptor modulators program, a novel class of compounds to regulate gene expression through the transrepression pathway while avoiding the transactivation pathway. The company was formerly known as Hanes Newco, Inc. and changed its name to Kala Pharmaceuticals, Inc. in December 2009.

Frequently asked questions

What percentage of Kala Pharmaceuticals is owned by insiders or institutions?
Currently 7.442% of Kala Pharmaceuticals shares are held by insiders and 18.54% by institutions.
How many people work for Kala Pharmaceuticals?
Latest data suggests 192 work at Kala Pharmaceuticals.
When does the fiscal year end for Kala Pharmaceuticals?
Kala Pharmaceuticals's fiscal year ends in December.
Where is Kala Pharmaceuticals based?
Kala Pharmaceuticals's address is: 1167 Massachusetts Avenue, Arlington, MA, United States, 02476
What is Kala Pharmaceuticals's ISIN number?
Kala Pharmaceuticals's international securities identification number is: US4831191030
What is Kala Pharmaceuticals's CUSIP number?
Kala Pharmaceuticals's Committee on Uniform Securities Identification Procedures number is: 483119103

More guides on Finder

Ask an Expert

You are about to post a question on

  • Do not enter personal information (eg. surname, phone number, bank details) as your question will be made public
  • is a financial comparison and information service, not a bank or product provider
  • We cannot provide you with personal advice or recommendations
  • Your answer might already be waiting – check previous questions below to see if yours has already been asked provides guides and information on a range of products and services. Because our content is not financial advice, we suggest talking with a professional before you make any decision.

By submitting your comment or question, you agree to our Privacy and Cookies Policy and Terms of Use.

Questions and responses on are not provided, paid for or otherwise endorsed by any bank or brand. These banks and brands are not responsible for ensuring that comments are answered or accurate.
Go to site